 Odonate Therapeutics NASDAQ:ODT was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report released on Friday, Zacks.com reports. According to Zacks, Odonate Therapeutics, LLC is a pharmaceutical company. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company focused ... 